- Report
- June 2023
- 83 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- October 2024
- 59 Pages
China
From €1638EUR$1,800USD£1,392GBP
- Report
- October 2024
- 135 Pages
China
From €1638EUR$1,800USD£1,392GBP
- Report
- March 2023
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Report
- October 2023
- 497 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP
- Report
- August 2023
- 389 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP
- Report
- February 2021
- 181 Pages
Europe
From €2365EUR$2,598USD£2,009GBP
€3379EUR$3,712USD£2,870GBP
- Book
- October 2019
- 720 Pages
Cephalosporins are a class of antibiotics used to treat a wide range of bacterial infections. They are derived from the fungus Cephalosporium and are closely related to penicillin. Cephalosporins are divided into four generations, each generation having a broader spectrum of activity than the previous one. They are used to treat infections of the respiratory tract, urinary tract, skin, and soft tissue. Cephalosporins are also used to treat some sexually transmitted diseases, such as gonorrhea.
Cephalosporins are widely used in both human and veterinary medicine. They are available in a variety of formulations, including tablets, capsules, suspensions, and injections. Cephalosporins are generally well tolerated, with few side effects.
Some companies in the Cephalosporins market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and AstraZeneca. Show Less Read more